Bayer acquires rights to Cytokinetics' heart drug in Japan

By Yahoo! Finance | Nov 19, 2024 at 03:26 AM EST

Bayer collaborates with U.S. biotech firm Cytokinetics to acquire rights in Japan for an experimental heart drug, strengthening its cardiovascular business. The deal includes upfront payment of 50 million euros and potential additional payments based on development and sales milestones.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.